We examined the differences in neurocognitive functions in individuals dependent on heroin (n = 120), pharmaceutical (n = 52), and natural opioids (n = 66) and compared with healthy controls (HC, n = 94). We estimated independent effects of the opioid groups on cognitive tests, adjusted for effect modifiers. Pharmaceutical opioid dependent group performed worse than HC in Wisconsin Card Sorting Test in conceptual level response and trials to complete first category. Pharmaceutical and heroin groups had higher error scores than HC in verbal and visual N-Back Tests (NBTs). There was no significant difference between pharmaceutical and heroin groups, but both had higher error scores than the natural opioid users in NBTs. Time to complete Trail Making- A test was higher in pharmaceutical than in natural opioid group. The natural opioid group required more trials than HC to complete the first category. Pharmaceutical opioid group had worst cognitive impairment. Cognitive functions are relatively spared in natural opioid-dependent group.
BaldacchinoA.BalfourD. J. K.PassettiF.HumphrisG.MatthewsK. (2012). Neuropsychological consequences of chronic opioid use: A quantitative review and meta-analysis. Neuroscience and Biobehavioral Reviews, 36(9), 2056–2068. https://doi.org/10.1016/J.NEUBIOREV.2012.06.006
3.
BassionyM. M.YoussefU. M.HassanM. S.Salah El-DeenG. M.El-GohariH.AbdelghaniM.AbdallaA.IbrahimD. H. (2017). Cognitive impairment and tramadol dependence. Journal of Clinical Psychopharmacology, 37(1), 61–66. https://doi.org/10.1097/JCP.0000000000000617
4.
BasuD.AggarwalM.DasP. P.MattooS. K.KulharaP.VarmaV. K. (2012). Changing pattern of substance abuse in patients attending a de-addiction centre in north India (1978-2008). The Indian Journal of Medical Research, 135(6), 830–836.
5.
BecharaA.DamasioA. R.DamasioH.AndersonS. W. (1994). Insensitivity to future consequences following damage to human prefrontal cortex. Cognition, 50(1–3), 7–15. https://doi.org/10.1016/0010-0277(94)90018-3
6.
BourgaultZ.Rubin-KahanaD. S.HassanA. N.SanchesM.Le FollB. (2021). Multiple substance use disorders and self-reported cognitive function in U.S. Adults: Associations and sex-differences in a nationally representative sample. Frontiers in Psychiatry, 12, 797578. https://doi.org/10.3389/FPSYT.2021.797578
7.
ContiA. A.McLeanL.TolomeoS.SteeleJ. D.BaldacchinoA. (2019). Chronic tobacco smoking and neuropsychological impairments: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews, 96(1), 143–154. https://doi.org/10.1016/j.neubiorev.2018.11.017
8.
ErscheK. D.SahakianB. J. (2007). The neuropsychology of amphetamine and opiate dependence: Implications for treatment. Neuropsychology Review, 17(3), 317–336. https://doi.org/10.1007/S11065-007-9033-Y
9.
GhoshA.BasuD.KhandelwalN.AhujaC. K.BNS.RanaD. (2019). Risk, reversibility and resilience of brain circuitries linked to opioid dependence: A diffusion tensor imaging study of actively opioid-using subjects and three comparison groups. Asian Journal of Psychiatry, 40(2), 107–115. https://doi.org/10.1016/J.AJP.2019.02.009
10.
GouldT. J. (2010). Addiction and cognition. Addiction Science and Clinical Practice, 5(2), 4–14.
11.
JaeggiS. M.BuschkuehlM.PerrigW. J.MeierB. (2010). The concurrent validity of the N-back task as a working memory measure. Memory (Hove, England), 18(4), 394–412. https://doi.org/10.1080/09658211003702171
12.
JansenM. G.GeerligsL.ClaassenJ. A. H. R.OverdorpE. J.BrazilI. A.KesselsR. P. C.OostermanJ. M. (2021). Positive effects of education on cognitive functioning depend on clinical status and neuropathological severity. Frontiers in Human Neuroscience, 15, 723728. https://doi.org/10.3389/fnhum.2021.723728
KrollS. L.NikolicE.BieriF.SoykaM.BaumgartnerM. R.QuednowB. B. (2018). Cognitive and socio-cognitive functioning of chronic non-medical prescription opioid users. Psychopharmacology, 235(12), 3451–3464. https://doi.org/10.1007/S00213-018-5060-Z
15.
LoeberS.KniestA.DiehlA.MannK.CroissantB. (2008). Neuropsychological functioning of opiate-dependent patients: A nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment. The American Journal of Drug and Alcohol Abuse, 34(5), 584–593. https://doi.org/10.1080/00952990802308239
16.
LövdénM.FratiglioniL.GlymourM. M.LindenbergerU.Tucker-DrobE. M. (2020). Education and cognitive functioning across the life span. Psychological Science in the Public Interest: A Journal of the American Psychological Society, 21(1), 6–41. https://doi.org/10.1177/1529100620920576
17.
MahintamaniT.GhoshA.JainR. (2021). Serious health threats of novel adulterants of the street heroin: A report from India during the COVID-19 pandemic. BMJ Case Reports, 14(8), e242239. https://doi.org/10.1136/bcr-2021-242239
18.
MelicharJ. K.HumeS. P.WilliamsT. M.DaglishM. R. C.TaylorL. G.AhmadR.MaliziaA. L.BrooksD. J.MylesJ. S.Lingford-HughesA.NuttD. J. (2005). Using [11C]diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: Clinical and preclinical studies. The Journal of Pharmacology and Experimental Therapeutics, 312(1), 309–315. https://doi.org/10.1124/jpet.104.072686
19.
MindtM. R.CoulehanK.AghvinianM.ScottT. M.OlsenJ. P.CunninghamC. O.AriasF.ArnstenJ. H. (2022). Underrepresentation of diverse populations and clinical characterization in opioid agonist treatment research: A systematic review of the neurocognitive effects of buprenorphine and methadone treatment. Journal of Substance Abuse Treatment, 135, 108644. https://doi.org/10.1016/j.jsat.2021.108644
NyhusE.BarcelóF. (2009). The Wisconsin card sorting test and the cognitive assessment of prefrontal executive functions: A critical update. Brain and Cognition, 71(3), 437–451. https://doi.org/10.1016/J.BANDC.2009.03.005
22.
RapeliP.KivisaariR.AuttiT.KähkönenS.PuuskariV.JokelaO.KalskaH. (2006). Cognitive function during early abstinence from opioid dependence: A comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry, 6, 9. https://doi.org/10.1186/1471-244X-6-9
23.
RichardsG. C.LlukaL. J.SmithM. T.HaslamC.MooreB.O’CallaghanJ.StrongJ. (2018). Effects of long-term opioid analgesics on cognitive performance and plasma cytokine concentrations in patients with chronic low back pain: A cross-sectional pilot study. Pain Reports, 3(4), e669. https://doi.org/10.1097/PR9.0000000000000669
24.
RobertsC.HortonA. M.Jr. (2001). Using the Trail Making test to screen for cognitive impairment in a drug abuse treatment sample. The International Journal of Neuroscience, 109(3–4), 273–280. https://doi.org/10.3109/00207450108986538
25.
Sanjari MoghaddamH.ShadlooB.ShahkhahH.TafakhoriA.HaghshomarM.MeshkatS.AghamollaiiV. (2021). Cognitive impairment in opium use disorder. Behavioural Neurology, 2021, 5548623. https://doi.org/10.1155/2021/5548623
26.
SarojR.GhoshA.SubodhB. N.NehraR.MahintamaniT.RanaD. K.BasuD. (2020). Neurocognitive functions in patients on buprenorphine maintenance for opioid dependence: A comparative study with three matched control groups. Asian Journal of Psychiatry, 53(10), 102181. https://doi.org/10.1016/J.AJP.2020.102181
27.
SchäferT.SchwarzM. A. (2019). The meaningfulness of effect sizes in psychological research: Differences between sub-disciplines and the impact of potential biases. Frontiers in Psychology, 10, 813. https://doi.org/10.3389/fpsyg.2019.00813
28.
ScottJ. C.WolfD. H.CalkinsM. E.BachE. C.WeidnerJ.RuparelK.MooreT. M.JonesJ. D.JacksonC. T.GurR. E.GurR. C. (2017). Cognitive functioning of adolescent and young adult cannabis users in the Philadelphia Neurodevelopmental Cohort. Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors, 31(4), 423–434. https://doi.org/10.1037/adb0000268
29.
ShiJ.ZhaoL. Y.CopersinoM. L.FangY. X.ChenY.TianJ.DengY.ShuaiY.JinJ.LuL. (2008). PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. European Journal of Pharmacology, 579(1–3), 160–166. https://doi.org/10.1016/j.ejphar.2007.09.042
30.
SoykaM.LiebM.KagererS.ZinggC.KollerG.LehnertP.LimmerC.KuefnerH.Hennig-FastK. (2008). Cognitive functioning during methadone and buprenorphine treatment: Results of a randomized clinical trial. Journal of Clinical Psychopharmacology, 28(6), 699–703. https://doi.org/10.1097/JCP.0B013E31818A6D38
31.
Spss. (2006). No Title (14.0).
32.
TittarelliR.Di LucaN. M.PacificiR.PichiniS.Del RioA.BusardòF. P. (2020). Commentary - heroin purity and adulteration: An updated snapshot from the Italian early warning system. European Review for Medical and Pharmacological Sciences, 24(8), 4461–4466. https://doi.org/10.26355/EURREV_202004_21028
33.
Transparency InternationalA. R. (2019). Annual report 2019 Υππαν. European Blood Alliance.
UpadhyayJ.AndersonJ.SchwarzA. J.CoimbraA.BaumgartnerR.PendseG.GeorgeE.NutileL.WallinD.BishopJ.NeniS.MaierG.IyengarS.EvelhochJ. L.BleakmanD.HargreavesR.BecerraL.BorsookD. (2011). Imaging drugs with and without clinical analgesic efficacy (pp. 2659–2673). https://doi.org/10.1038/NPP.2011.156
36.
UpadhyayJ.MalekiN.PotterJ.ElmanI.RudraufD.KnudsenJ.WallinD.PendseG.McDonaldL.GriffinM.AndersonJ.NutileL.RenshawP.WeissR.BecerraL.BorsookD. (2010). Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain: A Journal of Neurology, 133(Pt 7), 2098–2114. https://doi.org/10.1093/BRAIN/AWQ138
37.
Verdejo-GarcíaA.López-TorrecillasF.GiménezC. O.Pérez-GarcíaM. (2004). Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse. Neuropsychology Review, 14(1), 1–41. https://doi.org/10.1023/B:NERV.0000026647.71528.83
38.
WangG. J.VolkowN. D.FowlerJ. S.LoganJ.AbumradN. N.HitzemannR. J.PappasN. S.PascaniK. (1997). Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 16(2), 174–182. https://doi.org/10.1016/S0893-133X(96)00184-4
39.
WarnerN. S.HansonA. C.SchulteP. J.HabermannE. B.WarnerD. O.MielkeM. M. (2022). Prescription opioids and longitudinal changes in cognitive function in older adults: A population-based observational study. Journal of the American Geriatrics Society, 70(12), 3526–3537. https://doi.org/10.1111/JGS.18030
40.
WollmanS. C.HausonA. O.HallM. G.ConnorsE. J.AllenK. E.SternM. J.StephanR. A.KimmelC. L.SarkissiansS.BarletB. D.Flora-TostadoC. (2019). Neuropsychological functioning in opioid use disorder: A research synthesis and meta-analysis. The American Journal of Drug and Alcohol Abuse, 45(1), 11–25. https://doi.org/10.1080/00952990.2018.1517262
